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(+)-Catechin inhibits heart mitochondrial complex I
and nitric oxide synthase: functional
consequences on membrane potential and
hydrogen peroxide production
Darío E. Iglesias, a,b Silvina S. Bombicino,a Alberto Boverisa,b and
Laura B. Valdez *a,b
In order to study the in vitro effect of flavan-3-ol (+)-catechin on the enzymatic activities of mitochon-
drial complex I and nitric oxide synthase (mtNOS), as well as the consequences on the membrane poten-
tial and H2O2 production rate, isolated mitochondria from rat heart were exposed to 3 nM to 100 μM
(+)-catechin. NADH–Q1 reductase (complex I) and mtNOS activities were inhibited 25% and 50%, res-
pectively, by the addition of 10 nM (+)-catechin to the reaction medium. Moreover, in the nM range,
(+)-catechin decreased state 4 mitochondrial membrane potential by about 10 mV, but failed to change
the membrane potential measured in the presence of ADP. (+)-Catechin (10 nM) inhibited not only
complex I activity, but also the H2O2 production rate (35%) sustained by malate–glutamate, in accordance
with the decrease observed in mitochondrial membrane potential. Considering (+)-catechin con-
centrations lower than 10 nM, linear and positive correlations were obtained between mitochondrial
complex I activity and either NO (r2 = 0.973) or H2O2 production rates (r
2 = 0.958), suggesting a
functional association among these parameters. Altogether, the results indicate that (+)-catechin, at nM
concentrations, inhibits mitochondrial complex I activity, leading to membrane potential decline and
consequently to reduction in H2O2 and NO production rates. The decrease in mtNOS activity could also be
a consequence of the direct action of (+)-catechin on the NOS structure, this effect being in accordance
with the functional interaction between complex I and mtNOS, as previously reported.
Introduction
The heart is an organ dependent on energy to maintain
normal contractile function, with mitochondria being the
organelles that generate 95% of cellular ATP by oxidative phos-
phorylation. In this process, complex I (NADH-ubiquinone
oxidoreductase) catalyzes the transfer of two electrons from
NADH via flavin mononucleotide (FMN) and a series of iron–
sulfur centers (Fe–S) to ubiquinone (UQ), in a reaction associ-
ated with proton translocation across the inner membrane,
contributing to the proton-motive force.1–3 Complex I is also a
major source of reactive oxygen species, producing superoxide
anion (O2
−) through the autoxidation reaction of flavin-semi-
quinone (FMNH•)4,5 or reduced FMN (FMNH2),
6 as well as ubi-
semiquinone.7 In the mitochondrial matrix, Mn-superoxide
dismutase (Mn-SOD) dismutates O2
− to produce hydrogen per-
oxide (H2O2).
8–11 In addition, O2
− reacts with nitric oxide (NO),
the latter species is produced by mitochondrial nitric oxide
synthase (mtNOS), an isoenzyme of the NOS family located in
the mitochondrial inner membrane.12–14 The reaction between
O2
− and NO yields the strong oxidant and nitrating compound,
peroxynitrite (ONOO−). When the steady-state concentration
of ONOO− is increased, tyrosine nitration, protein oxidation
and damage to Fe–S centers might take place,15–17 leading to
complex I inhibition. Dysfunction of complex I is found in
clinical conditions such as Parkinson’s disease,18–21 ischemia–
reperfusion,22,23 endotoxic shock24 and aging;25–27 and it is
usually accompanied by changes in mtNOS activity,20,22–25
increases in H2O2 and ONOO
− production rates and oxidative
and/or nitrosative damage. This finding agrees with the
reported functional interaction between complex I and
mtNOS28–31 and with the dependence of mitochondrial NO
production on membrane potential.30,32,33
Many studies have shown that polyphenols attenuate the
progression of diseases associated with oxidative stress and
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mitochondrial dysfunction.34,35 It has been described that,
within the cells, mitochondria can accumulate flavonoids.36,37
Plant polyphenols – flavonoids and non-flavonoids – are redu-
cing agents that function as antioxidants by virtue of the
hydrogen-donating properties of their phenolic hydroxyl
groups as well as by their transition metal-chelating abilities.
The aromatic hydroxyl groups of flavonoids produce an anti-
oxidant pharmacophore comparable to the chroman moiety of
tocopherols. Indeed, a high reactivity of flavonoids with rad-
icals such as O2
−, hydroxyl radical (HO•) and NO has been
reported.38–40 However, the effectiveness of flavonoids as cellu-
lar antioxidants cannot be accounted for solely in terms of
their chemical antioxidant capacity because of the lack of cor-
relation between the reduction potential of flavonoids and
their ability to afford protection against oxidative stress.41
Furthermore, the data from dietary bioavailability of flavonoids
point out that the physiologic plasma concentration of total
metabolites does not exceed 10 µM.42 The bioavailability of fla-
vonoids also depends on the dietary sources, and it has been
shown that total flavonoid metabolites can reach plasma con-
centrations of up to 4.0 µM with an intake of 50 mg aglycone
equivalents, except for isoflavones that can reach higher con-
centrations.43 Thus, although many studies support the
hypothesis that the protective effects of flavonoids are related
to their intrinsic antioxidant properties, many other modes of
action for catechins have been suggested.44–46 Indeed, it has
been previously reported that flavonoids can cause high inhi-
bition of cellular reactive oxygen species production through
inhibition of redox enzymes like NAD(P)H oxidases,47,48
xanthine oxidase,49 monooxygenases, cyclooxygenases and
lipooxygenases,50 as reviewed by Gutierrez-Merino et al.51
Considering that (+)-catechin, a flavan-3-ol present in green
and black teas and many other plant foods, has shown ben-
eficial effects on cardiovascular pathological processes, such
as ischemia/reperfusion-induced tissue injury52 and hyperten-
sion,53 and that flavonoids can accumulate in mitochon-
dria,36,37 the aim of this work was to study the in vitro effect of
(+)-catechin, in the nM to low μM concentration range, on
heart mitochondrial complex I and mtNOS activities, as well as




The flavonoid (+)-catechin, recombinant nNOS (N3033, from
rat brain) and other chemicals were purchased from Sigma
Chemical Co. (St Louis, MO, USA). Other reagents were of
analytical grade.
Heart mitochondria isolation and mitochondrial membrane
preparation
Sprague–Dawley female rats of 6–7 weeks of age (200–220 g)
were housed in cages in an environmentally controlled facility
at 25 °C. The animals were subjected to circadian light–dark
cycles, fed standard rat chow, and provided water ad libitum.
Animals were sacrificed under a CO2 atmosphere; hearts were
removed, washed and weighed. The procedures used in this
study were approved by the Animal Care and Research
Committee of the School of Pharmacy and Biochemistry,
University of Buenos Aires (CICUAL; 0027118/2017), and this
investigation was in accordance with the International Guiding
Principles for Biomedical Involving Animals (ICLAS).
The heart mitochondrial fraction was obtained from whole
heart homogenates through differential centrifugation, using a
Sorvall RC5C centrifuge (Sorvall-Instruments-Du Pont, Model
RC5S). Hearts were homogenized in a glass-Teflon homogen-
izer in a medium consisting of 230 mM mannitol, 70 mM
sucrose, 10 mM Tris-HCl, and 1 mM EDTA, pH 7.40 (MSTE) at
a ratio of 1 g tissue per 9 ml of medium. The homogenate was
centrifuged at 700g for 10 min to remove nuclei and cell
debris, the sediment was discarded and the supernatant was
centrifuged at 8000g for 10 min to precipitate mitochondria.
The pellet was washed twice and resuspended in the same
buffer.54 This suspension consisted of mitochondria able to
carry out oxidative phosphorylation. The whole procedure was
carried out at 0–4 °C.
Mitochondrial membranes were obtained by three cycles of
freezing and thawing of mitochondrial preparations and hom-
ogenized by passage through a 25-gauge hypodermic needle.55
Mitochondrial complex I activity
Complex I activity was studied following NADH–cytochrome c
reductase (complex I–III) and NADH–Q1 reductase (complex I)
activities. Absorbance changes were monitored using a
Beckman DU 7400 diode array spectrophotometer, at 30 °C.
In order to measure NADH–cytochrome c reductase activity,
mitochondrial membranes suspended in 100 mM KH2PO4/
K2HPO4, pH 7.40 (0.01–0.03 mg protein per ml) were pre-incu-
bated for 2 min in the absence or in the presence of 1.0 to 50
nM of (+)-catechin. Then, 0.2 mM NADH, 25 μM cytochrome
c3+, and 0.5 mM KCN were added. Cytochrome c reduction was
performed at 550–540 nm (ε = 19 mM−1 cm−1) and the enzy-
matic activity was expressed as nmol cyt. c2+ per min per mg
protein, taking into account the absorbance changes sensitive
to rotenone (1 µM) addition.56
NADH–Q1 reductase activity was measured in a medium
consisting of 10 mM Tris-HCl, 1 mM EDTA, and 50 mM KCl, at
pH 7.40. Mitochondrial membranes (0.01–0.03 mg protein per
ml) were pre-incubated for 2 min in the absence or in the pres-
ence of 10 nM to 100 μM (+)-catechin. After that, 75 μM NADH,
50 μM 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-
benzoquinone (ubiquinone-1 or Q1), 2 mM KCN, and 1 μM
antimycin were added, and NADH consumption was carried
out at 340–380 nm (ε = 5.5 mM−1 cm−1). As the control, the
effect of 1 µM rotenone was tested. Complex I activity was
expressed as nmol NADH per min per mg protein.57
Nitric oxide synthase activity
Nitric oxide synthase activity was determined performing the
oxidation of oxyhemoglobin (HbO2) to methemoglobin at
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577–591 nm (ε = 11.2 mM−1 cm−1) using a Beckman DU 7400
diode array spectrophotometer, at 37 °C.55,58
The NO production rate by heart mitochondrial mem-
branes, i.e. mtNOS activity, was measured in a reaction
medium consisting of 100 mM KH2PO4/K2HPO4, pH 7.40,
1 mM CaCl2, 100 μM NADPH, 10 μM dithiothreitol (DTT),
4 μM Cu, Zn-SOD, 0.1 μM catalase, 1 mM L-arginine, 20 μM
HbO2, and mitochondrial membranes (0.20–0.30 mg protein
per ml) pre-incubated for 2 min in the absence or in the pres-
ence of 1.0 to 25 nM of (+)-catechin.
The NO production sustained by rat recombinant
nNOS was measured in a reaction medium consisting of
50 mM HEPES, pH 7.40, 1 mM CaCl2, 100 μM NADPH,
170 μM DTT, 10 μM tetrahydrobiopterin (BH4), 1 μM cal-
modulin, 50 μM L-arginine, 5 μM HbO2 and 0.05–0.18 units
per ml nNOS. The effect of 3 and 10 nM of (+)-catechin was
tested.31
In order to consider the NOS inhibitor-sensitive HbO2 oxi-
dation, control experiments adding 2 mM Nω-monometil-L-
arginine (L-NMMA) were performed. The absorbance changes
that were inhibited by L-NMMA were expressed as nmol NO per
min per mg protein or nmol NO per min per U.
Mitochondrial membrane potential
Mitochondrial membrane potential (ΔΨ) was determined by
measuring rhodamine 123 (Rh-123) fluorescence at
503–527 nm (λexc-em) with a Hitachi F-3010 spectrofluorometer,
at 30 °C.32,59,60 Rhodamine-123 was dissolved in ethanol and
its concentration was assayed spectrophotometrically at
507 nm (ε = 101 mM−1 cm−1). The ethanol concentration in
the measuring medium was kept below 0.2% (v/v).
The fluorescence of the media containing 150 mM sucrose,
2 mM MgCl2, 5 mM KH2PO4/K2HPO4, 30 mM KOH-HEPES,
pH 7.40, and 0.1 μM Rh-123 was determined before addition
of the mitochondrial suspension. This measurement was
used as an indication of the total dye concentration ([Rh-
123]total, in nmol μl−1). The heart mitochondrial suspension
(0.10–0.20 mg protein per ml) was pre-incubated for 2 min in
the absence or in the presence of 10 nM, 100 nM or 5.0 μM
(+)-catechin and added to the reaction media. In order to
establish resting respiration (state 4), 6 mM malate and 6 mM
glutamate were added. State 3 respiration was achieved by the
addition of 0.5 mM ADP. The hyperpolarization or depolariz-
ation of mitochondria was induced by 1 μM oligomycin or
1 μM m-CCCP addition, respectively. After an equilibration
time, the fluorescence of the suspension was measured and
the content of the cuvette was centrifuged at 15 000g to pellet
mitochondria. The Rh-123 concentration remaining in the
media ([Rh-123]out, in nmol μl−1) was calculated from the fluo-
rescence values of the supernatant. The initial total amount
of Rh-123 in the cuvette ([Rh-123]total) and the amount
remaining in the media ([Rh-123]out) were used to calculate by
subtraction the total amount of Rh-123 taken up by mito-
chondria ([Rh-123]mit, in nmol per mg protein). The concen-
tration of free Rh-123 in the matrix ([Rh-123]in, in nmol μl−1)
was calculated using the following equation, and the bind-
ing partition coefficients at 30 °C are (Ki = 26 μl mg−1,
Ko = 120 μl mg−1):61
½Rh-123mit ¼ Ki ½Rh-123in þ Ko ½Rh-123out
Mitochondrial membrane potentials (negative inside) were
calculated by using the electrochemical Nernst–Guggenheim
equation: ΔΨ = 59 log([Rh-123]in/[Rh-123]out).
Mitochondrial hydrogen peroxide production
Mitochondrial H2O2 production was performed fluorometri-
cally at 365–450 nm (λexc-em), at 30 °C, through the scopoletin-
horseradish peroxidase (HRP) assay,62 using a Hitachi F-3010
fluorescence spectrophotometer. The reaction medium con-
sisted of 230 mM mannitol, 70 mM sucrose, and 20 mM Tris-
HCl, pH 7.40, added with 0.5 μM Cu, Zn-SOD, 1 μM HRP,
1 μM scopoletin and coupled mitochondrial suspensions
(0.10–0.30 mg protein per ml) pre-incubated for 2 min in the
absence or in the presence of 1–100 nM (+)-catechin.
Mitochondrial H2O2 production rates were tested in state 4
using 6 mM malate and 6 mM glutamate as complex I sub-
strates. A calibration curve was recorded using H2O2
(0.05–0.35 μM) as the standard, previously titrated spectropho-
tometrically at 240 nm (ε = 43.6 M−1 cm−1) to express the fluo-
rescence changes as nmol H2O2 per min per mg protein.
Protein concentration and statistics
Protein concentration was determined with the Folin reagent63
using bovine serum albumin as the standard. Results included
in tables and figures are expressed as means ± SEM of four or
five independent experiments. Dunnet’s t test was used to
analyze the significance of differences between paired determi-
nations. The 0.01 or 0.05 probability levels were used as a cri-
terion for biological significance. Statistical analysis was per-
formed using GraphPad Instat4 (GraphPad Software, La Jolla,
CA, USA).
Results
Mitochondrial complex I activity
The effect of (+)-catechin on mitochondrial complex I was
studied measuring NADH–Q1 reductase (complex I) and
NADH–cytochrome c reductase (complex I–III) activities
(Fig. 1). NADH–Q1 reductase activity was 25% inhibited by the
addition of 10 nM (+)-catechin to the reaction medium. The
maximal inhibitory effect of this polyphenol on NADH–Q1
reductase activity was observed at 100 μM (+)-catechin; under
this experimental condition, only 50% of complex I activity
has been detected. As it was expected, the addition of 1 µM
rotenone produced the almost complete (>95%) inhibition of
complex I activity (data not shown). Taking into account that
cytochrome c is a molecular target of flavonoids,64 NADH–cyto-
chrome c activity could not be an adequate technique to study
the in vitro effect of (+)-catechin on complex I activity. Despite
the fact that the inhibitory effect was not statistically signifi-
cant and was less noticeable than when NADH–Q1 reductase
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activity was measured, the influence of the addition of nM
concentrations of (+)-catechin was also observed when
complex I–III activity was measured (Fig. 1 inset): NADH–cyto-
chrome c reductase activity was 10% reduced by 25 nM
(+)-catechin.
Thus, in the nM range, (+)-catechin inhibited complex I
measured not only by the NADH–Q1 reductase assay but also
by the NADH–cytochrome c reductase technique, suggesting
an action of this flavan-3-ol on the complex I structure.
Mitochondrial membrane potential
In order to evaluate the effect of mitochondrial complex I inhi-
bition by (+)-catechin on mitochondrial membrane potential
(ΔΨ), the fluorescence changes associated with Rh-123 distri-
bution were measured in the absence or in the presence of 10
nM to 5 μM (+)-catechin, using malate–glutamate as the sub-
strate of complex I (Fig. 2). In the nM range, (+)-catechin
decreased state 4 ΔΨ (Fig. 2A) but failed to change the mem-
brane potential measured in the presence of ADP (state 3;
Fig. 2B). The membrane potential corresponding to state 4 res-
piration was reduced in 10 mV when mitochondria were
exposed to 10 nM (+)-catechin. Although these changes were
not statistically significant, the shift observed towards lower
membrane potentials is highly relevant under physiological
conditions. The physiological mitochondrial ΔΨ is in a narrow
range, between 150 (state 3) and 175 mV (state 4), where small
changes in the potential are causative of depolarization. Thus,
the difference in the membrane potential of mitochondria
moving from a state 4 to a state 3 is not higher than
15–25 mV.32 Membrane potential values detected during
resting respiration, in the presence of 100 nM or 5 μM (+)-cate-
chin, were similar to the one registered in the presence of 10
nM of this polyphenol, suggesting that this membrane poten-
tial-inhibition degree is the highest effect of this compound
under the assayed experimental conditions. This observation
is in agreement with the uncoupling effect exerted by classical
uncoupling agents, such as FCCP or mCCCP.5
Hydrogen peroxide and nitric oxide production rates
Considering that complex I produces O2
−, the stoichiometric
precursor of H2O2, the effect of (+)-catechin on mitochondrial
production of this latter species was measured using malate–
glutamate as the complex I substrate. (+)-Catechin reduced
state 4 mitochondrial H2O2 production (Fig. 3A) in a concen-
tration dependent manner. At 10 nM (+)-catechin, the H2O2
production rate was reduced by 35%. The supplementation of
Fig. 1 Effect of (+)-catechin on mitochondrial complex I. NADH–Q1 reductase (complex I) and NADH–cytochrome c reductase (complex I–III;
inset) activities as a function of (+)-catechin concentration. Results are expressed as mean ± SEM of 5 independent experiments. *p < 0.05, **p <
0.01 in the presence vs. in the absence of (+)-catechin.
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the reaction medium with 1 μM rotenone produced an
enhancement in the H2O2 production rate of about 50%
(0.72 ± 0.03 nmol per min per mg protein). When the mito-
chondrial suspension was pre-incubated in the presence of
5 µM (+)-catechin, H2O2 production was decreased by 40%, the
same reduction degree that has been detected in the presence
of 100 nM (+)-catechin, indicating that the inhibition observed
at 100 nM was the maximal in vitro effect of (+)-catechin on
H2O2 generation.
Taking into account the reported functional interaction
between complex I and mtNOS activities,28,31 and the regu-
lation of mitochondrial NO production by membrane poten-
tial,30,32,33 mtNOS activity was measured and the effect of
1.0–25 nM (+)-catechin was studied. This concentration range
was selected according to the effects of that flavonoid on
complex I activity and mitochondrial membrane potential.
Fig. 3B shows that (+)-catechin inhibited NO production of
heart mitochondrial membranes in a concentration dependent
manner. Mitochondrial NOS activity showed a hyperbolic
decay as a function of (+)-catechin concentration. At 10 nM
(+)-catechin, a decline of about 50% in mitochondrial NO pro-
duction was observed.
In addition, NO production by rat recombinant nNOS was
assayed in an attempt to study the effect of (+)-catechin on the
NOS structure. Table 1 shows that NO production was inhib-
ited when nNOS activity was evaluated in the presence of 3 or
10 nM (+)-catechin, suggesting a direct action of this flavonoid
on the enzyme structure. At 10 nM (+)-catechin, the recombi-
nant nNOS activity was 45% decreased.
Moreover, considering the results obtained in the presence
of (+)-catechin concentrations lower than 10 nM, linear and
positive correlations were obtained (Fig. 3C) between mito-
chondrial NADH–Q1 reductase activity and H2O2 production
rate (r2 = 0.958) and between NADH–Q1 reductase and mtNOS
activities (r2 = 0.973), suggesting a functional association
among these mitochondrial parameters.
Discussion
It has been reported that flavonoids can exert effects not only
through antioxidant but also by non-antioxidant mechanisms,
which can be combined to protect the cell against injury.
Thus, flavonoids can act by virtue of their free radical scaven-
ging properties, their transition metal-chelating abilities or by
enzymatic activities modulation.65,66 In the present work, the
addition of nM concentrations of (+)-catechin to the reaction
medium inhibited not only mitochondrial complex I activity
(Fig. 1) but also the H2O2 production rate sustained by malate–
glutamate (Fig. 3A), in accordance with the decrease observed
in mitochondrial membrane potential (Fig. 2). These results
agree with the finding of Lagoa et al.64 who have shown that
quercetin and kaempferol inhibit rotenone-sensitive
NADH : Q1 oxidoreductase activity in submitochondrial par-
ticles and the H2O2 production sustained by this complex, in
rat brain mitochondria. These authors argue that the inhi-
Fig. 2 Effect of (+)-catechin on mitochondrial membrane potential
(ΔΨ) of mitochondria energized by malate–glutamate in the absence (A)
and in the presence (B) of ADP. Hyperpolarization or depolarization of
mitochondria was induced by 1 μM oligomycin or 1 μM m-CCCP
addition, respectively, and was included as controls. Results are
expressed as mean ± SEM of 5 independent experiments. ND: not
detectable.
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bition of complex I activity depends on the concentration of
ubiquinone added to the medium, suggesting that quercetin
and kaempherol affect the binding of the coenzyme to the
enzyme.64 The inhibition of the electron transfer chain at
complex I by kaempferol was also reported by Filomeni et al.,67
who have shown that the pre-treatment of HeLa cells with
200 μM kaempferol inhibited malate–glutamate supported res-
piration, whereas no significant effect was observed in succi-
nate supported respiration.
As a consequence of the inhibition of complex I activity
exerted by (+)-catechin, the proton pumping by this complex
could be affected, explaining the registered ΔΨ reduction. It is
important to point out that the state 4 ΔΨ was 10 mV lower in
the presence of the flavonoid than in its absence. According to
Gerencser et al.,68 this difference in the voltage value implies a
2-fold reduction in the maximal rate of mitochondrial ATP pro-
duction in isolated mitochondria. In addition, it is known that
the mitochondrial O2
− production rate, i.e. of the stoichio-
metric precursor of mitochondrial H2O2, depends not only on
the reduction degree of the components of the respiratory
chain but also on the mitochondrial membrane potential.8,10
It was recognized that ionophores, protophores and com-
pounds that collapse ΔΨ regulate the rates of H2O2 pro-
duction.8,10,54,69,70 Korshunov et al.69 reported a hyperbolic
relationship between membrane potential and H2O2 pro-
duction in rat heart mitochondria with a threshold value that
exceeds the state 3 ΔΨ level, above which a very strong increase
in H2O2 production takes place. Hansford et al.
71 showed that
active H2O2 production by heart mitochondria requires both a
high fractional reduction of complex I and a high membrane
potential. According to Skulachev,72 a slight uncoupling of
mitochondrial respiration leads to a moderate decrease in
membrane potential, preventing O2
− and consequently H2O2
generation. Thus, nM concentrations of (+)-catechin could lead
to a mild uncoupling of mitochondrial respiration sustained
by substrates of complex I, the latter, the major entry point for
electrons from NADH produced by the tricarboxylic acid cycle.
In addition, (+)-catechin inhibited NO production sustained
by mtNOS. In the nM range, mtNOS activity showed a hyper-
Fig. 3 Effect of (+)-catechin on mitochondrial H2O2 (A) and NO (B) production rates. Linear correlations between complex I and mtNOS activities
(open circles), or complex I activity and H2O2 production rate (closed circles) (C) considering [(+)-catechin] concentration to be lower than 10 nM.
Results are expressed as mean ± SEM of 5 independent experiments. **p < 0.01 in the presence vs. in the absence of (+)-catechin.





(nmol NO min−1 U−1)
0.0 1.30 ± 0.10
3.0 0.67 ± 0.05**
10 0.71 ± 0.07**
Results are expressed as mean ± SEM of 4 independent experiments.
**p < 0.01 in the presence vs. in the absence of (+)-catechin.
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bolic decay as a function of (+)-catechin concentration
(Fig. 3B). Furthermore, when the effect of 10 nM (+)-catechin
was tested on NO production catalyzed by recombinant nNOS,
as a prototype of the NOS isoform located in mitochondria,12
that flavonoid produced a decrease of about 45% in NO gene-
ration, suggesting that (+)-catechin could inhibit mtNOS
activity through a direct action on the enzyme structure.
Taking into account the quantity and the activity of the recom-
binant nNOS used (Table 1), it is possible to estimate the ratio
between the concentration of the (+)-catechin added (3–10 nM)
and the concentration of the pure enzyme. Accordingly, con-
sidering 200 U per mg protein from the data sheet of rat
recombinant nNOS (N3033, Sigma Chemical Co.), and the
maximal concentration of nNOS used under the assayed con-
ditions, i.e. 0.18 U nNOS per ml, and 300 000 g mol−1 as MW
of nNOS, the estimated concentration of nNOS in the reaction
medium is ∼3 nM. In this situation, the ratio (+)-catechin :
recombinant nNOS is about 1 : 1. Therefore, the enzyme
mtNOS is probably saturated when the effect of 1 to 25 nM
(+)-catechin on NO production by heart mitochondria (nmol
NO per min per mg total mitocondrial protein) is evaluated,
because of that under this experimental condition the specific
amount of mtNOS is expected to be lower than the quantity of
recombinant NOS. This fact could explain why higher concen-
trations of (+)-catechin do not produce a greater inhibitory
effect on mtNOS activity.
The combined decline in H2O2 and NO production rates is
in agreement with the reported functional interaction between
complex I and mtNOS proteins22,23,29,31 and with the results
obtained by Franco et al.28 who have shown that complex I pro-
teins from rat liver mitochondria co-immunoprecipitate with
mtNOS. Moreover, data from our laboratory have shown that
heart mitochondrial inside-out particles produce NO sup-
ported by succinate-dependent reversed electron flow in the
respiratory chain, emphasizing the notion that mtNOS and
complex I proteins are functionally associated31 and contigu-
ously located. The mtNOS and complex I association is compa-
tible not only with the concept of respiratory chain supercom-
plex formation with strong protein–protein interactions,73,74
but also with the dependence of mtNOS activity on the meta-
bolic states and membrane potential. We have previously
shown that mitochondrial NO production exponentially
depends on mitochondrial membrane potential;30,32,33 and
this dependence is more pronounced in the physiological
range of membrane potential (150–175 mV), where small
changes in the ΔΨ produce noticeable variations of mitochon-
drial NO release. Several studies have shown that abolishing
ΔΨ inhibits NO production by mtNOS activity, suggesting a
tight regulatory interplay between mitochondrial membrane
potential and NO production.32,33,75 Therefore, in coupled
mitochondria, the fall in ΔΨ due to the addition of (+)-cate-
chin could lead not only to the decrease in H2O2 production
but also in NO generation by mtNOS.
Despite the emerging interest in the beneficial actions of
polyphenols over mitochondria, there is little information
regarding bioavailability and internalization of these bioactive
compounds by the organelles. However, it has been shown
that flavonoids can accumulate in mitochondria.36,37,76
According to Stevens et al.77 the physicochemical properties of
polyphenols, such as lipophilicity and pKa, actually favor their
enrichment in mitochondria. Since (+)-catechin has favorable
pKa1 (8.68 ± 0.23), close to the physiological pH of the cytosol
and mitochondrial compartments, and distribution coefficient
(log P = 0.61), it would able to reach the mitochondrial matrix
and exert its biological effects within the organelle. According
to our results, (+)-catechin, in the nM concentration range,
inhibits mitochondrial complex I activity leading to a mem-
brane potential decrease and consequently to H2O2 production
reduction. The decrease in mitochondrial NO generation could
be a consequence of the direct action of (+)-catechin on the
NOS structure, and also correlates with the functional inter-
action between complex I and mtNOS and the dependence of
mtNOS activity on ΔΨ (Fig. 4).
Conclusion
Physiologically relevant concentrations of (+)-catechin could
modulate the mitochondrial redox state and the generation of
signaling molecules, such as H2O2 and NO, through non-anti-
Fig. 4 Schematic representation showing the in vitro effects of nM to
low μM concentrations of (+)-catechin on mitochondrial complex I
activity, membrane potential (ΔΨ) and H2O2 and NO productions.
Straight lines indicate pathways supported by the results included in this
work and dotted lines suggest pathways reported by bibliography.
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oxidant mechanisms. In this context, the mitochondrial




mtNOS Mitochondrial nitric oxide synthase
NO Nitric oxide
ΔΨ Mitochondrial membrane potential
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